spacer
home > pmps > winter 2002 > containment solutions: solids charging into process vessels
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Containment Solutions: Solids Charging into Process Vessels

Vessel charging in the process plant has long been identified as a major source of dust emission. Now, with increasing use of active pharmaceutical ingredients (APIs) in the processing and manufacturing stages, the need for assured operator protection is increasing the requirement for effective dust containment. The maximum permissible operator exposure level (OEL) considered in this article is 10µg/m3.

What are the Available Options?

Containment during vessel charging falls into two key categories:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Martyn Ryder, Managing Director of Extract Technology
Martyn Ryder is the Managing Director of Extract Technology, part of the Carlisle Life Science Group. He was educated at Leeds Polytechnic in HVAC and Building Services.

In 1981 he founded Extract Technology, a supplier of pharmaceutical dust control and high containment systems, based in Huddersfield, UK.

spacer
Martyn Ryder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

PCI Pharma Services

Recently, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mold on paracetamol (acetaminophen) tablets (1). It discovered the product was shipped by sea from India to multiple companies in the UK at temperatures reaching up to 60 degrees Celsius. Labeling for paracetamol tablets typically states they should be kept below 30 degrees Celsius. In addition, MHRA discovered the humidity levels exceeded 80 percent during shipping, which is too high for the packaging that was used.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement